(Q39485125)

12 September 2017

title

Antitumor activity of a novel histone deacetylase inhibitor (S)-HDAC42 in oral squamous cell carcinoma (English)

1 reference

12 September 2017

Li-Yuan Bai

1

1 reference

12 September 2017

Chang-Fang Chiu

2

1 reference

12 September 2017

Shiow-Lin Pan

3

1 reference

12 September 2017

Aaron M Sargeant

4

1 reference

12 September 2017

Tzong-Ming Shieh

5

1 reference

12 September 2017

Ying-Chu Wang

6

1 reference

12 September 2017

Jing-Ru Weng

7

1 reference

12 September 2017

language of work or name

English

0 references

publication date

23 August 2011

1 reference

12 September 2017

1 reference

12 September 2017

volume

47

1 reference

12 September 2017

issue

12

1 reference

12 September 2017

page(s)

1127-1133

1 reference

The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide

12 September 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1124/MOL.105.017145

Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1158/1078-0432.CCR-06-0429

Histone deacetylase inhibitors sensitize prostate cancer cells to agents that produce DNA double-strand breaks by targeting Ku70 acetylation.

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1158/0008-5472.CAN-06-3996

Identifiers

DOI

10.1016/J.ORALONCOLOGY.2011.07.031

1 reference

12 September 2017

1 reference